This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
3 HMO Stocks to Consider as Aetna (AET) Falls Out of Favor
by Zacks Equity Research
Aetna Inc. (AET) has been grappling with a number of issues of late, which are clearly reflected in its share price underperformance relative to the sector.
Can Universal Health's (UHS) Latest Buyout Drive Growth?
by Zacks Equity Research
Universal Health Services, Inc. (UHS) recently announced that it has completed the acquisition of Cambian Group, PLC's Adult Services Division
The Ensign Group Buys 15 Assisted Living Operation Assets
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) recently announced that it has acquired the underlying real estate of 15 assisted living operations in Wisconsin.
U.S. Economy Slowing Again?
by Sheraz Mian
The U.S. economy's growth trajectory may be uneven, but it is not headed towards a recession.
This Week's Top Value Stocks: (CB)(UNH)
by Tracey Ryniec
Zacks value stock strategist, Tracey Ryniec, discusses Chubb Limited (CB) and Unitedhealth Group (UNH).
5 Dow Stocks to Buy This Summer
by Jeremy Mullin
Will this be the summer for the Dow? The season will typically bring about lower volatility, count on the boring blue chips to drift higher.
Health Insurance Industry Outlook - October 2016
by Zacks Equity Research
Health insurance companies have performed favorably, with most of the players reporting an increase in the top line along with membership growth.
Health Insurers Suffer on High Costs, Unprofitable Exchanges
by Zacks Equity Research
A fragile global economy presents a headwind for insurers looking to expand their international operations.
Health Insurers Face Regulatory Scrutiny, Exchange Issues
by Zacks Equity Research
Legislation has undoubtedly altered the regulatory landscape in ways that are not always beneficial to a private health insurer's bottom line.
The Zacks Analyst Blog Highlights: UnitedHealth, 21st Century Fox, Sanofi, MasterCard and Barclays
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, 21st Century Fox, Sanofi, MasterCard and Barclays